Evidence map›Paper›PMID 40745021›Full record

ArticleCommunications engineering2025

Range-compensated pencil beam scanning proton Arc therapy: a feasibility study.

Blake R Smith, Ryan T Flynn, Alonso N Gutiérrez, Daniel E Hyer

Abstract read
In one paragraph

Article in Communications engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Blake R SmithDepartment of Radiation Oncology, University of Iowa Health Care, Iowa City, IA, 52242, USA. blake-smith@uiowa.edu.ORCID http://orcid.org/0009-0000-0117-2590
Ryan T FlynnDepartment of Radiation Oncology, University of Iowa Health Care, Iowa City, IA, 52242, USA.
Alonso N GutiérrezDepartment of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, 33176, USA.
Daniel E HyerDepartment of Radiation Oncology, University of Iowa Health Care, Iowa City, IA, 52242, USA.ORCID http://orcid.org/0000-0002-7638-9599

Funding

Sharpening the edge in pencil-beam proton therapy: an aftermarket collimation system to better spare normal tissue during radiation treatmentR37CA226518 · NCI · UNIVERSITY OF IOWA · PI HYER, DANIEL ELLIS · 2018 to 2024
$3.1M
NCI NIH HHS R37 CA226518U.S. Department of Health & Human Services | National Institutes of Health (NIH) R37CA226518
6 · The paper itself

Abstract

Proton arc therapy is a conceptual treatment technique in proton therapy that delivers a scanned proton pencil beam simultaneously as the gantry is rotated around the patient, exploiting the geometric advantages of a continuous arc with the dosimetric advantages of protons to maximize healthy tissue sparing. Here we propose an alternative approach to deliver pencil beam scanning (PBS) proton arc therapy using a beam-modifying device called a SpeleoFilter. SpeleoFilters can improve the treatment efficiency of proton arc by reducing the number of beam energies and beam spots while preserving the plan quality as compared to traditional multifield intensity modulated proton therapy (IMPT). The proposed SpeleoFilter framework was validated within a state-of-the art PBS collimator and IBA Dedicated Nozzle PBS system at the Miami Cancer Institute. The Monte Carlo methods developed in this work showed great agreement with experimental measurements and matched depth dose profiles within a 1-2%/1 mm gamma criteria. Proton arc treatments utilizing a SpeoleFilter resulted in comparable healthy tissue sparing and an order-of-magnitude reduction in the number of energy layers compared to IMPT for both phantom and patient datasets. Further work is necessary to fully demonstrate its application and clinical integration for multiple treatment sites.

Identifiers

PMID40745021
PMCPMC12313954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.